|Rapid Review Complete
|For the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation not Recommended
The HSE has approved reimbursement following confidential price negotiations.